$85.0M
sold in all offerings
Protego Biopharma, Inc. is a corporation based in San Diego, CA in the Other Health Care industry group. From December 17, 2019 to December 3, 2025 it filed 3 private fundraising filings for 3 offerings and reported $85 million sold in all.
Updated November 11, 2026 · newest filing Dec 3, 2025
Amount sold
$85.0M
All offerings, newest filing of each
Offered
$182.5M
Total amount sought
Offerings
3
3 filings with amendments
Newest offering
$32.9M
Sold, first filed Dec 3, 2025
Investors
18
In the newest offering
Min. investment
-
In the newest offering
Facts
- Type
- Corporation
- Place
- San Diego, CA
- Industry group
- Other Health Care
- Listed
- No
- First filing
- December 17, 2019
- Newest filing
- December 3, 2025
- Exemptions
- 506(b), 504, 4(a)(5)
- Other names
- Protego Biopharma
Amount sold by year
Each offering in the year of its first filing, at its newest amount sold
Amount sold by year
Offerings
3 offerings, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| Dec 3, 2025 | $32.9M | $130.4M | 18 | - | 506(b) | Equity |
| Oct 28, 2021 | $51.0M | $51.0M | 6 | - | 506(b) | Equity |
| Dec 17, 2019 | $1.0M | $1.0M | 3 | - | 504, 506(b), 4(a)(5) | Equity, Options or warrants, Securities on exercise of options |
Filing history
3 filings, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Dec 3, 2025 | New offering | $32.9M | $130.4M | 18 |
| Oct 28, 2021 | New offering | $51.0M | $51.0M | 6 |
| Dec 17, 2019 | New offering | $1.0M | $1.0M | 3 |
Related pages
Questions and answers
How much has Protego Biopharma, Inc. raised in private offerings?
$85 million sold in 3 private offerings reported from Dec 17, 2019 to Dec 3, 2025, counting each offering once at its newest filing.
When did Protego Biopharma, Inc. last file about a private offering?
December 3, 2025. Its newest offering reported $32.9 million sold of $130 million offered to 18 investors.
Which exemption does Protego Biopharma, Inc. use?
506(b), 504, 4(a)(5). Rule 506(b) does not allow public advertising.
Is Protego Biopharma, Inc. a listed company?
No ticker is linked to this issuer, so it is private or no longer listed.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.